packageRomidepsin

romidepsin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Romidepsin is an anticancer drug used to treat lymphoma, including cutaneous T-cell lymphoma (mycosis fungoides) and other mature T-cell lymphomas. It is approved for use, mainly in the treatment of T-cell lymphomas, though a marketing application was refused in the European Union.

Summary written by glm-5.3-flash from Wikidata Q7363205 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:romidepsin
ATC codes:L01XH02, L01XX39
DrugBank:DB06176
PubChem CID:57515973
ChEBI:61080
Wikidata:Q7363205
formula:C24H36N4O6S2
molar mass:540.694 g/mol (PubChem CID 57515973)
logP:2.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown